This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Glaxosmithkline LLC. Active years: 2024-2026.
Company Filing History:
Years Active: 2024-2026
Title: Innovations in Myelofibrosis Treatment by Gregg David Smith
Introduction
Gregg David Smith is an accomplished inventor based in Plymouth, MI (US). He has made significant contributions to the field of medicine, particularly in the treatment of myelofibrosis. His innovative approaches have the potential to improve patient outcomes and enhance the quality of life for those affected by this condition.
Latest Patents
Smith holds a patent for "Platelet count-agnostic methods of treating myelofibrosis." This patent outlines a reanalysis of the SIMPLIFY 1 and 2 trials data, indicating that momelotinib (MMB) is effective in JAKi-naïve patients and as a second-line therapy to RUX. The methods described in the patent provide benefits such as reducing enlarged spleens, improving myelofibrosis-related symptoms, and increasing transfusion independence in patients at risk for thrombocytopenia due to the underlying disease and RUX therapy. The patent details methods for administering a therapeutically effective amount of momelotinib or a pharmaceutically acceptable salt to subjects identified as having myelofibrosis and a platelet count of less than 150×10/L.
Career Highlights
Gregg David Smith is associated with GlaxoSmithKline LLC, where he continues to work on innovative treatments for myeloproliferative neoplasms. His dedication to research and development has positioned him as a key figure in advancing therapeutic options for patients suffering from myelofibrosis.
Collaborations
Some of Smith's notable coworkers include Barbara Jane Klencke and Rafe Michael Joseph Donahue. Their collaborative efforts contribute to the ongoing research and development of effective treatments in the field.
Conclusion
Gregg David Smith's work in developing methods for treating myelofibrosis showcases his commitment to improving patient care through innovation. His contributions are vital in the ongoing fight against this challenging condition.